It has been reported that TAMs reside in hypoxic tumor regions and significantly upregulate the expression of regulated in development and DNA damage responses 1 (REDD1), which inhibits mammalian target of rapamycin (mTOR) activity [13]. The gene discussed is MTOR; the disease is neoplasm.